Two Bag System for Diabetic Ketoacidosis (2BagDKA)
Primary Purpose
Diabetic Ketoacidosis
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Two bag system
Sponsored by
About this trial
This is an interventional treatment trial for Diabetic Ketoacidosis focused on measuring intravenous fluids, adults, two bag system
Eligibility Criteria
Inclusion Criteria:
Diagnosis of diabetic ketoacidosis defined as:
- Blood sugar greater than 250 mg/dl
- Venous pH less than 7.25
- Bicarbonate less than 18
- Evidence of ketone formation with either positive urine ketones or elevated beta-hydroxybutyrate > 3
- Anion gap greater than 10 +/ - 2 (or higher than expected anion gap corrected for albumin)
- 18-85 years of age
Exclusion Criteria:
- Pregnancy
- Hyperglycemic hyperosmolar state
- Ketosis from other etiology such as starvation or alcoholic ketosis
- Acute exacerbation of congestive heart failure
- Acute coronary syndrome or non-ST elevation MI
- Pulmonary edema from other cause such as decompensated liver failure or acute renal failure
- Renal failure requiring renal replacement therapy (hemodialysis)
- Septic shock
Sites / Locations
- MetroHealth Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Usual care
Two bag system
Arm Description
Usual care with a one bag system of IV fluids, as recommended in the American Diabetes Association consensus statement guidelines from 2009.
A two bag system of IV fluids will be used during insulin infusion administration.
Outcomes
Primary Outcome Measures
Time to anion gap closure in hours
Anion gap (Na - Cl - HCO3) is within normal range when corrected for the albumin (time to anion gap closure will be defined as the time to the first occurrence of a normal anion gap).
Secondary Outcome Measures
Hypoglycemic episodes
Symptomatic episodes of hypoglycemia
Hypoxic events
Desaturations less than 89% requiring supplemental oxygen
Pulmonary edema
Pulmonary edema seen on either chest X-ray or with the change in the lung exam
Chest pain with EKG changes
Onset of new chest pain with new EKG changes concerning for ischemia
Hyponatremia events
Sodium values less than 135 mmol/L (corrected for glucose)
Hypokalemia events
Potassium values less than 3.3 mmol/L
ICU length of stay
Total time the patient was admitted in the stepdown unit and/or medical ICU
Changes in mental status
Worsening in either CAM-ICU score or Glasgow Coma Scale
Total volume of intravenous fluids administered
Total volume of intravenous fluids administered
Full Information
NCT ID
NCT03660189
First Posted
September 4, 2018
Last Updated
June 15, 2023
Sponsor
MetroHealth Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT03660189
Brief Title
Two Bag System for Diabetic Ketoacidosis
Acronym
2BagDKA
Official Title
The "Two Bag" System for Treatment of Adults With Diabetic Ketoacidosis: a Prospective Randomized Study
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
September 17, 2018 (Actual)
Primary Completion Date
June 15, 2023 (Actual)
Study Completion Date
June 15, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
MetroHealth Medical Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This is a study investigating the best way to treat diabetic ketoacidosis (DKA) with intravenous (IV) fluids in the hospital. The purpose of this study is to determine whether the "two bag" system of administering IV fluids for the treatment of adults with DKA leads to a shorter time requiring intravenous insulin (a shorter time to anion gap closure), when compared to usual care the traditional "one bag" system of IV fluids. Participants will be assigned randomly to either the usual care group or the "two bag" system group. Based on studies performed in the past, the investigators predict that patients treated with the two bag system of IV fluids for DKA will have a significantly shorter time requiring treatment with intravenous insulin when compared to the traditional one bag system.
Detailed Description
The two bag system has been studied in the pediatric population and is used frequently in pediatric intensive care units. It involves two bags of identical fluids with electrolytes, except one bag has 0% dextrose and the other has 10% dextrose. The two fluid bags run simultaneously into a single IV. The rates of the two fluid bags are adjusted according to the patient's blood sugar. Since the hyperglycemia in DKA typically corrects before the ketosis, this provides a more efficient method of titrating the dextrose concentration based on the patient's needs, while continuing to infuse the insulin at a constant rate to prevent further ketogenesis. The benefits of the two bag system from the pediatric literature include: decreased response time to IV fluid changes, decreased time to correction of bicarbonate and ketones, and decreased total IV fluid volume administered. There was one retrospective study of the two bag system in adults, which showed decreased time to anion gap closure and decreased hypoglycemic events. To this date, there are no prospective randomized trials to evaluate the efficacy of the two bag system in adults.
Patients admitted with DKA in the critical care pavilion will be randomized to either the "two bag system" or "usual care" group.
Patients in both groups will be treated for DKA with IV fluid resuscitation for dehydration and an insulin infusion according to usual care, recommended at 0.1 U/kg/hr.
The two bag system of IV fluids will be ordered as delineated below:
If blood sugar is > 300, run D10 solution at 0 ml/hr and saline solution at 200 ml/hr.
If blood sugar is 250-299, run D10 solution at 50 ml/hr and saline solution at 150 ml/hr.
If blood sugar is 200-249, run D10 solution at 100 ml/hr and saline solution at 100 ml/hr.
If blood sugar is 150-199, run D10 solution at 150 ml/hr and saline solution at 50 ml/hr.
If blood sugar is < 150, run D10 solution at 200 ml/hr and saline solution at 0 ml/hr.
The control group will be usual care of DKA based on the American Diabetes Association Guidelines using a "one bag system."
In both groups, blood sugars will be checked every hour while on the insulin drip. A basic metabolic panel will be checked every 4 hours to monitor the anion gap. Once the anion gap is closed on two occasions and the subject is able to tolerate an enteral diet, the patient will be transitioned to subcutaneous insulin and insulin drip will be discontinued.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetic Ketoacidosis
Keywords
intravenous fluids, adults, two bag system
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
57 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Usual care
Arm Type
No Intervention
Arm Description
Usual care with a one bag system of IV fluids, as recommended in the American Diabetes Association consensus statement guidelines from 2009.
Arm Title
Two bag system
Arm Type
Experimental
Arm Description
A two bag system of IV fluids will be used during insulin infusion administration.
Intervention Type
Other
Intervention Name(s)
Two bag system
Intervention Description
The two IV fluid bags have identical fluids and electrolytes, except one has 10% dextrose and the other has no dextrose. The two fluid bags run simultaneously and their rates are adjusted according to the patient's blood sugar.
Primary Outcome Measure Information:
Title
Time to anion gap closure in hours
Description
Anion gap (Na - Cl - HCO3) is within normal range when corrected for the albumin (time to anion gap closure will be defined as the time to the first occurrence of a normal anion gap).
Time Frame
During hospitalization
Secondary Outcome Measure Information:
Title
Hypoglycemic episodes
Description
Symptomatic episodes of hypoglycemia
Time Frame
During hospitalization
Title
Hypoxic events
Description
Desaturations less than 89% requiring supplemental oxygen
Time Frame
During hospitalization
Title
Pulmonary edema
Description
Pulmonary edema seen on either chest X-ray or with the change in the lung exam
Time Frame
During hospitalization
Title
Chest pain with EKG changes
Description
Onset of new chest pain with new EKG changes concerning for ischemia
Time Frame
During hospitalization
Title
Hyponatremia events
Description
Sodium values less than 135 mmol/L (corrected for glucose)
Time Frame
During hospitalization
Title
Hypokalemia events
Description
Potassium values less than 3.3 mmol/L
Time Frame
During hospitalization
Title
ICU length of stay
Description
Total time the patient was admitted in the stepdown unit and/or medical ICU
Time Frame
During hospitalization
Title
Changes in mental status
Description
Worsening in either CAM-ICU score or Glasgow Coma Scale
Time Frame
During hospitalization
Title
Total volume of intravenous fluids administered
Description
Total volume of intravenous fluids administered
Time Frame
During hospitalization
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosis of diabetic ketoacidosis defined as:
Blood sugar greater than 250 mg/dl
Venous pH less than 7.25
Bicarbonate less than 18
Evidence of ketone formation with either positive urine ketones or elevated beta-hydroxybutyrate > 3
Anion gap greater than 10 +/ - 2 (or higher than expected anion gap corrected for albumin)
18-85 years of age
Exclusion Criteria:
Pregnancy
Hyperglycemic hyperosmolar state
Ketosis from other etiology such as starvation or alcoholic ketosis
Acute exacerbation of congestive heart failure
Acute coronary syndrome or non-ST elevation MI
Pulmonary edema from other cause such as decompensated liver failure or acute renal failure
Renal failure requiring renal replacement therapy (hemodialysis)
Septic shock
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vidya Krishnan, MD
Organizational Affiliation
MetroHealth Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
MetroHealth Medical Center
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44109
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
No current plan to share individual participant data at this time.
Citations:
PubMed Identifier
17130218
Citation
Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA. Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006 Dec;29(12):2739-48. doi: 10.2337/dc06-9916. No abstract available.
Results Reference
background
PubMed Identifier
10064682
Citation
Grimberg A, Cerri RW, Satin-Smith M, Cohen P. The "two bag system" for variable intravenous dextrose and fluid administration: benefits in diabetic ketoacidosis management. J Pediatr. 1999 Mar;134(3):376-8. doi: 10.1016/s0022-3476(99)70469-5.
Results Reference
background
PubMed Identifier
23055897
Citation
So TY, Grunewalder E. Evaluation of the two-bag system for fluid management in pediatric patients with diabetic ketoacidosis. J Pediatr Pharmacol Ther. 2009 Apr;14(2):100-5. doi: 10.5863/1551-6776-14.2.100.
Results Reference
background
PubMed Identifier
28878933
Citation
Munir I, Fargo R, Garrison R, Yang A, Cheng A, Kang I, Motabar A, Xu K, Loo LK, Kim DI. Comparison of a 'two-bag system' versus conventional treatment protocol ('one-bag system') in the management of diabetic ketoacidosis. BMJ Open Diabetes Res Care. 2017 Aug 11;5(1):e000395. doi: 10.1136/bmjdrc-2017-000395. eCollection 2017.
Results Reference
background
PubMed Identifier
15583776
Citation
Poirier MP, Greer D, Satin-Smith M. A prospective study of the "two-bag system'' in diabetic ketoacidosis management. Clin Pediatr (Phila). 2004 Nov-Dec;43(9):809-13. doi: 10.1177/000992280404300904.
Results Reference
background
Learn more about this trial
Two Bag System for Diabetic Ketoacidosis
We'll reach out to this number within 24 hrs